Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 02/09/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/09/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/09/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/09/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/09/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/02/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/02/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/02/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 11/08/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/31/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
